O'Shea J, Derton A, Henson J, Iqbal K, et al. Real-World Uptake and Clinical Outcomes of Long-Acting Injectable
Cabotegravir/rilpivirine in the United States, 2021-2023. J Acquir Immune Defic Syndr 2026 Feb 26. doi: 10.1097/QAI.0000000000003855.
PMID: 41747094
|